Skip to content
BiologicalX

Comparison

Modafinil vs N-Acetyl Cysteine

Side-by-side of Modafinil and N-Acetyl Cysteine. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Modafinil

  • FDA approved in 1998 for narcolepsy, with later additions for shift-work sleep disorder and OSA residual sleepiness
  • Schedule IV controlled substance in the US; prescription-only in EU, UK, Australia
  • Increases wakefulness via weak dopamine reuptake inhibition plus histaminergic, noradrenergic, and orexinergic activation
  • Long half-life of 12 to 15 hours requires morning dosing to avoid sleep disruption
  • Modest cognitive enhancement signal in non-sleep-deprived adults at 100 to 200 mg (Battleday meta-review 2015)
  • Substantial CYP3A4 induction reduces hormonal contraceptive efficacy; barrier methods recommended

N-Acetyl Cysteine

  • Replenishes intracellular glutathione by supplying cysteine, the rate-limiting amino acid for synthesis
  • First-line antidote for acetaminophen toxicity, restoring hepatic glutathione before fulminant injury occurs
  • Reduces sputum viscosity in chronic bronchitis and COPD at 600 to 1200 mg/day over months
  • Modest symptom reductions in OCD and trichotillomania at 1200 to 2400 mg/day across small RCTs
  • Mixed evidence for psychiatric adjunct use in bipolar depression and schizophrenia negative symptoms
  • Inhaled forms can trigger bronchospasm in active asthma; oral use is the standard biohacker route

Side-by-side

Attribute Modafinil N-Acetyl Cysteine
Category pharmaceutical supplement
Also known as Provigil, Modalert, Modvigil, diphenylmethylsulfinyl-acetamide NAC
Half-life (hr) 13 5.6
Typical dose (mg) 200 1200
Dosing frequency daily, morning 1 to 3 times daily, split dosing preferred
Routes oral oral, iv
Onset (hr) 1 1
Peak (hr) 3 2
Molecular weight 273.35 163.19
Molecular formula C15H15NO2S C5H9NO3S
Mechanism Weak dopamine reuptake inhibition plus downstream activation of histaminergic, noradrenergic, and orexinergic wake-promoting systems. Deacetylated to cysteine, the rate-limiting precursor for glutathione synthesis; also directly scavenges reactive oxygen species and modulates glutamate signaling.
Legal status Schedule IV (US); prescription-only globally; not a supplement OTC in most jurisdictions; restricted periods in US history (FDA reclassified 2022)
WADA status banned allowed
DEA / Rx Schedule IV OTC supplement (US, post-2022); Rx indications also exist (acetaminophen overdose, mucolytic)
Pregnancy Not recommended Used clinically in pregnancy for specific indications; consult clinician
CAS 68693-11-8 616-91-1
PubChem CID 4236 12035
Wikidata Q422968 Q413299

Safety profile

Modafinil

Common side effects

  • headache
  • nausea
  • anxiety
  • insomnia (with late-day dosing)
  • dry mouth
  • mild blood pressure elevation

Contraindications

  • recent myocardial infarction
  • unstable angina
  • left ventricular hypertrophy
  • significant arrhythmia
  • history of Stevens-Johnson syndrome
  • psychotic disorders
  • pregnancy
  • concurrent MAOI use

Interactions

  • hormonal contraceptives: CYP3A4 induction reduces contraceptive efficacy; use barrier method(major)
  • cyclosporine: reduced cyclosporine levels via CYP3A4 induction(major)
  • warfarin: CYP2C9 inhibition raises INR(moderate)
  • phenytoin: CYP2C19 inhibition raises phenytoin levels(moderate)
  • MAOIs: potential hypertensive reaction(major)
  • classical stimulants (amphetamine, methylphenidate): additive cardiovascular and sleep-disruption effects(moderate)

N-Acetyl Cysteine

Common side effects

  • sulfur-like taste or odor
  • nausea
  • flatulence
  • diarrhea

Contraindications

  • active asthma attack (inhaled form can trigger bronchospasm)
  • known NAC hypersensitivity

Interactions

  • nitroglycerin: potentiates vasodilation, risk of hypotension and headache(moderate)
  • activated charcoal: reduces NAC absorption when used for acetaminophen overdose(moderate)
  • anticoagulants: theoretical additive antiplatelet effect at high doses(minor)

Which Should You Take?

N-Acetyl Cysteine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC, oral dosing, with a Tier-A outcome catalogued. Modafinil is the right call when one of the conditionals below applies.

  • If your priority is wakefulness, pick Modafinil.
  • If your priority is focus or working memory, pick Modafinil.
  • If your priority is healthspan extension, pick N-Acetyl Cysteine.
  • If your priority is post-training recovery, pick N-Acetyl Cysteine.

Edge case: If you want to avoid controlled substance, N-Acetyl Cysteine is the more accessible choice.

Default choice: N-Acetyl Cysteine. Wider use case, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Modafinil only if your priority sits squarely in the goals it owns above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Modafinil and N-Acetyl Cysteine?

Modafinil and N-Acetyl Cysteine differ in category (pharmaceutical vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Modafinil or N-Acetyl Cysteine?

Modafinil half-life is 13 hours; N-Acetyl Cysteine half-life is 5.6 hours.

Can you stack Modafinil with N-Acetyl Cysteine?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper